http://www.sciencedirect.com/science/article/pii/S0002934309003404
Choose an option to locate/access this article:
Check if you have access through your login credentials or your institution
Check accessAbstract
Background
The
Drug Burden Index (DBI), a measure of exposure to anticholinergic and
sedative medications, has been independently associated with physical
and cognitive function in a cross-sectional analysis of
community-dwelling older persons participating in the Health, Aging and
Body Composition study. Here we evaluate the association between DBI and
functional outcomes in Health, Aging and Body Composition study
participants over 5 years.
Methods
DBI
was calculated at years 1 (baseline), 3, and 5, and a measure of the
area under the curve for DBI (AUCDB) over the whole study period was
devised and calculated. Physical performance was measured using the
short physical performance battery, usual gait speed, and grip strength.
The association of DBI at each time point and AUCDB with year 6
function was analyzed in data from participants with longitudinal
functional measures, controlling for sociodemographics, comorbidities,
and baseline function.
Results
Higher
DBI at years 1, 3, and 5 was consistently associated with poorer
function at year 6. On multivariate analysis, a 1-unit increase in AUCDB
predicted decreases in short physical performance battery score of .08 (P = .01), gait speed of .01 m/s (P = .004), and grip strength of .27 kg (P = .004) at year 6.
Conclusion
Increasing
exposure to medication with anticholinergic and sedative effects,
measured with DBI, is associated with lower objective physical function
over 5 years in community-dwelling older people.
Keywords
- Clinical pharmacology;
- Geriatrics;
- Physical function
No comments:
Post a Comment